.png){kind=icon}
Return
Cross-presentation by dendritic cells
.png){kind=icon}
PRE
AI
DOI：10.1038/nri3254.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The presentation of exogenous antigens on MHC class I molecules, known as cross-presentation, is essential for the initiation of CD8(+) T cell responses. In vivo, cross-presentation is mainly carried out by specific dendritic cell (DC) subsets through an adaptation of their endocytic and phagocytic pathways. Here, we summarize recent advances in our understanding of the intracellular mechanisms of cross-presentation and discuss its role in immunity and tolerance in the context of specialization between DC subsets. Finally, we review current strategies to use cross-presentation for immunotherapy.
Keywords:
MHC CLASS-I
CD8(+) T-CELLS
RECOMBINANT ADENYLATE-CYCLASE
CONTROLS PHAGOSOMAL PH
MINOR H-ANTIGENS
STEADY-STATE
ENDOPLASMIC-RETICULUM
SELF-TOLERANCE
NADPH OXIDASE
CUTTING EDGE
Journal
IF:
60.9
Papers:
4.2K
Citations:
6.5W
Organization
Cited Papers
ShareSaveShareSaveCD8α+ Dendritic Cells Are the Critical Source of Interleukin-12 that Controls Acute Infection by Toxoplasma gondii Tachyzoites.png)
IMMUNITY
OAAI
IMMUNITYIF26.3
OAAIShareSave
View more